| Patent application number | Description | Published |
|---|
| 20080210396 | Measurement System for Improved Paper Roll Runnability - A system for measuring both caliper and tension of a web such as paper wound into a roll. The system may include a standard caliper sensor whose air supply is selectively modified to allow for both the measurement of caliper and tension of the web. In another embodiment two similar or identical measurement devices are installed in tandem where one device measures tension without pinching the sheet and the other device measures caliper. The sensor may include two sheet guides for providing support for tension measurement or one or both sheet guides can be eliminated by support from machinery rolls. | 09-04-2008 |
| 20090056156 | Web Measurement Device - A sensor is provided that measures web caliper using optical and magnetic measuring devices. The optical measuring devices may employ a confocal chromatic aberration method to accurately determine the distance to the moving web and the magnetic devices may be ferrite core coil and target. Means of stabilizing a moving web are included for improving dynamic measurement accuracy. | 03-05-2009 |
| 20090059232 | Web Measurement Device - A sensor is provided that measures web caliper using optical and magnetic measuring devices. The optical measuring devices may employ a confocal chromatic aberration method to accurately determine the distance to the moving web and the magnetic devices may be ferrite core coil and target. Means of stabilizing a moving web are included for improving dynamic measurement accuracy. | 03-05-2009 |
| 20090059244 | Web Measurement Device - A sensor is provided that measures web caliper using optical and magnetic measuring devices. The optical measuring devices may employ a confocal chromatic aberration method to accurately determine the distance to the moving web and the magnetic devices may be ferrite core coil and target. Means of stabilizing a moving web are included for improving dynamic measurement accuracy. | 03-05-2009 |
| 20090088889 | Accurate Tracking Of Web Features Through Converting Processes - There is described a method and apparatus for tracking the location of web features through a converting process, one application of which can involve tracking paper defects from a paper machine as detected by a camera system, to a winder where the sheet is wound to rolls so that the web defects can be repaired in the winder before making the rolls. The method to track web features is based on pattern identification of inherent sheet variability or defects. The apparatus involves two or more sheet property or defect monitoring web sensors arranged at the same cross directional location at different stages of the converting operation, augmented by tachometers and/or roll diameter sensors. A full automation system for drive control on the winder based on this information is preferably added to make maximum advantage of this information. | 04-02-2009 |
| 20090168749 | Synchronized Wireless Networked System - A sheet making system that has two or more separated nodes one of which may be a scanner sensing head and the other of which may be a scanner end column. Each node has a wireless system and receives power from a common AC source. Each node receives events data associated with the wireless system. Each wireless system has a circuit that obtains from the common AC power source an associated events data acquisition clock that is the same for all of the wireless systems to time synchronize to each other the associated events data signals at each of the two or more nodes. A central computer may be connected to the two or more nodes. The communication between the computer and each of the two or more nodes can be wireless or by a LAN or other mechanisms. | 07-02-2009 |
| Patent application number | Description | Published |
|---|
| 20090042224 | METHODS FOR DIAGNOSIS AND/OR PROGNOSIS OF OVARIAN CANCER - In one embodiment, methods are provided for assessing the presence of mesothelin-expressing tumor cells in a human subject. In another embodiment, methods are provided for monitoring the efficacy of treatment of a human cancer patient diagnosed with a mesothelin-expressing tumor. | 02-12-2009 |
| 20090104684 | Diagnosis of carcinomas - The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble and cell surface forms of HE4a polypeptides, including HE4a that is overexpressed in ovarian carcinomas. In particular the invention provides a nucleic acid sequence encoding HE4a, and also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a HE4a polypeptide with a molecule naturally occurring in soluble and/or cell surface form in a sample from such a subject, and by hybridization screening using an HE4a nucleotide sequence, as well as other related advantages. | 04-23-2009 |
| 20100047818 | DIAGNOSIS OF CARCINOMAS - The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble and cell surface forms of HE4a polypeptides, including HE4a that is overexpressed in ovarian carcinomas. In particular the invention provides a nucleic acid sequence encoding HE4a, and also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a HE4a polypeptide with a molecule naturally occurring in soluble and/or cell surface form in a sample from such a subject, and by hybridization screening using an HE4a nucleotide sequence, as well as other related advantages. | 02-25-2010 |
| 20110104675 | Methods and Compositions for Diagnosing Carcinomas - The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble forms of mesothelin polypeptides, including mesothelin related antigen (MRA). In particular the invention provides a nucleic acid sequence encoding MRA and an MRA variant. The invention also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a mesothelin polypeptide with a molecule naturally occurring in soluble form in a sample from such a subject, and by hybridization screening using an MRA nucleotide sequence, as well as other related advantages. | 05-05-2011 |
| Patent application number | Description | Published |
|---|
| 20090042224 | METHODS FOR DIAGNOSIS AND/OR PROGNOSIS OF OVARIAN CANCER - In one embodiment, methods are provided for assessing the presence of mesothelin-expressing tumor cells in a human subject. In another embodiment, methods are provided for monitoring the efficacy of treatment of a human cancer patient diagnosed with a mesothelin-expressing tumor. | 02-12-2009 |
| 20090104684 | Diagnosis of carcinomas - The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble and cell surface forms of HE4a polypeptides, including HE4a that is overexpressed in ovarian carcinomas. In particular the invention provides a nucleic acid sequence encoding HE4a, and also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a HE4a polypeptide with a molecule naturally occurring in soluble and/or cell surface form in a sample from such a subject, and by hybridization screening using an HE4a nucleotide sequence, as well as other related advantages. | 04-23-2009 |
| 20110104675 | Methods and Compositions for Diagnosing Carcinomas - The invention is directed to compositions and methods for the detection of a malignant condition, and relates to the discovery of soluble forms of mesothelin polypeptides, including mesothelin related antigen (MRA). In particular the invention provides a nucleic acid sequence encoding MRA and an MRA variant. The invention also provides a method of screening for the presence of a malignant condition in a subject by detecting reactivity of an antibody specific for a mesothelin polypeptide with a molecule naturally occurring in soluble form in a sample from such a subject, and by hybridization screening using an MRA nucleotide sequence, as well as other related advantages. | 05-05-2011 |
